ScreenerHero

ARDSAridis Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · aridispharma.com
0.0001USD0.00%Mkt Cap: 4457 $P/E: —

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product can…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap4.46K $
Enterprise Value4.81M $
Revenue (TTM)22.36M $
Gross Profit5.21M $
Net Income (TTM)-30.37M $
Revenue/Share0.6950 USD
Last Price0.0001 USD
Fiscal Year EndDec 2022
MR QuarterSep 2023
Employees37
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-13.86
EV/Revenue0.22
P/S0.00
P/B-0.00
EPS (TTM)-0.01
EPS (Forward)-0.09
52W Range
0.00010% of range0.0500
52W High0.0500 USD
52W Low0.0001 USD
Profitability
Gross Margin23.28%
Oper. Margin-208.39%
EBITDA Margin-1.55%
Profit Margin-5.11%
ROE125.33%
ROA-206.68%
Growth
Revenue Growth4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.13M $
CapEx (TTM)82.00K $
FCF Margin-73.28%
FCF Yield-367623.96%
Net Debt4.80M $
Net Debt/EBITDA-13.85
Balance Sheet
Debt/Equity-0.25
Current Ratio0.23
Quick Ratio0.03
Book Value/Sh-0.2650 USD
Cash/Share0.0010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.44.57M
Float40.31M
Insiders0.00%
Institutions11.44%
Short Interest
Short Ratio0.2d
Short % Float6.80%
Short % Out.5.55%
Shares Short2.00M
Short (prev mo.)439.68K
Technical
SMA 500.0005 (-80.7%)
SMA 2000.0005 (-81.7%)
Beta3760.16
S&P 52W Chg18.16%
Avg Vol (30d)5.66K
Avg Vol (10d)4.84K
Technical Indicators
RSI (14)39.9
MACD-0.0001
MACD Signal-0.0001
MACD Hist.+0.0000
BB Upper0.0001 USD
BB Middle0.0001 USD
BB Lower0.0001 USD
BB Width0.00%
ATR (14)0.0001 USD
Vol Ratio (20d)0.13x